Fairbanks Capital Management’s Allergan plc AGN Stock Holding History

Fairbanks Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,402	Closed	-$791K	–	53
2019 Q1	$791K	Sell	5,402 -44	-0.8%	-$6.38K	0.81%	23
2018 Q4	$728K	Sell	5,446 -608	-10%	-$99.7K	0.81%	24
2018 Q3	$1.15M	Hold	6,054	–	–	1.15%	21
2018 Q2	$1.01M	Buy	6,054 +67	+1%	+$10.8K	1.18%	20
2018 Q1	$1.01M	Sell	5,987 -1,016	-15%	-$170K	1.02%	20
2017 Q4	$1.15M	Buy	7,003 +376	+6%	+$67.5K	1.05%	23
2017 Q3	$1.36M	Buy	6,627 +1,147	+21%	+$267K	1.32%	23
2017 Q2	$1.33M	Buy	5,480 +70	+1%	+$16.4K	1.25%	20
2017 Q1	$1.29M	Buy	5,410 +479	+10%	+$112K	1.27%	15
2016 Q4	$1.04M	Buy	4,931 +769	+18%	+$159K	1.07%	15
2016 Q3	$959K	Buy	4,162 +859	+26%	+$210K	1.03%	15
2016 Q2	$763K	Buy	+3,303	New	+$762K	0.92%	16

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairbanks Capital Management's AGN Position: Q2 2019 in Review

Fairbanks Capital Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 5,402 shares — an estimated $791K sold.

Fairbanks Capital Management first reported a position in AGN in Q2 2016 and held it in 12 quarters. The position peaked at $1.36M in Q3 2017. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Fairbanks Capital Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Fairbanks Capital Management sold 5,402 Allergan plc shares in Q2 2019, an estimated $791K.
Fairbanks Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 12 quarters.
Fairbanks Capital Management's Allergan plc position peaked at $1.36M in Q3 2017.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Fairbanks Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.